New Drug: Perjeta for the treatment of HER2-positive metastatic breast cancerNew drug is a recombinant, humanized, monoclonal antibody. Intermittent versus continuous prostate cancer therapy: New trial raises cautions in metastatic diseaseResearchers unable to conclude the two strategies produce equivalent results Made-in-Canada technology aims to zap early prostate cancer Safety trial of MRI-guided ultrasound ablation launched in Ontario MRI an option for colon screening? Technique has the advantage of avoiding radiation exposure New retinoblastoma discovered Stivarga: new oral kinase inhibitor for metastatic colorectal cancer Drug acts by inhibiting multiple protein kinases, including those involved in tumour angiogenesis and oncogenesis. Patients on androgen-deprivation therapy receive inadequate bone health care Most lack basic information about bone health, are not receiving appropriate screening, and are not engaging in appropriate healthy bone behaviours, study finds. Bone tumour imaging goes multi-modal No mention of HPV testing in new national guidelines for cervical screening Ontario use of HPV test delayed until at least 2014 Meta-analysis shows folic acid unlikely to increase cancer risk But findings should be viewed with caution, observers say First Previous 44 45 46 47 48 Next Last
